Posted by Michael Wonder on 23 Nov 2021
Why is aducanumab priced at $56,000 per patient? Lessons for drug pricing reform.
20 November 2021 - Aducanumab’s price can inform the drug pricing policy debate because it responds to key features of the market environment for physician administered drugs: Medicare’s reimbursement formula, payment to physicians for infused drugs, and cost sharing requirements.
